InsidersTradesSigma
Discover the complete record of transactions filed by Tulipano Stephen J, 首席财务官. Director active across 1 company, notably Stoke Therapeutics, Inc.. In total, 1 disclosures have been logged. Activity tracked since 2 June 2022. The latest transaction was disclosed on 2 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Stephen J. Tulipano is the CFO at Stoke Therapeutics, Inc. He oversees the financial management of the company, including budgeting and financial performance analysis. His role is crucial in ensuring Stoke's financial health and supporting its growth initiatives.